When an authoritative person weighs in on a topic, we sit up and take notice. Dr. Ardeshir (Art) Rastinehead is an Interventional Urologic Oncologist and he is impressively credentialed. His experience includes fellowship training at the National Cancer Institute (NIH) with. Peter A. Pinto and Bradford J. Wood, pioneers in the research and development of keep reading
Everyone knows that money doesn’t buy happiness. But can it buy life? A new study out of the University of Washington Medical Center suggests that prostate cancer patients in extreme financial distress are more likely to die than those who are not. This doesn’t mean that having money can buy life, but hardship is a keep reading
When an authoritative person weighs in on a topic, we sit up and take notice. Dr. Ardeshir (Art) Rastinehead is an Interventional Urologic Oncologist and he is impressively credentialed. His experience includes fellowship training at the National Cancer Institute (NIH) with. Peter A. Pinto and Bradford J. Wood, pioneers in the research and development of keep reading
I never cease to be amazed at the amount of publication that comes from various individuals and teams at the University College London. On top of their clinical work with patients, and conducting clinical trials, I am impressed with their commitment and energy level when it comes to setting fingers to keyboard and writing articles keep reading
For decades, researchers have been looking for a link between prostate cancer and other health factors such as obesity, smoking, or diet. They don’t have to look very hard. There is a huge amount of evidence that links prostate cancer risk with these and other conditions—making a powerful case for making healthy choices. But what keep reading
Before the U.S. Preventive Services Task Force Panel’s 2012 recommendation against broad PSA screening, the blood test was commonly offered to men age 50 and over (45 if you had known risk factors). The Panel’s directive started a push in the opposite direction, encouraging doctors to discuss with each patient the merits and downsides of keep reading
It is always gratifying for a doctor when something he or she wholeheartedly believes in gets affirmed by published research. For me, this is the case with a new Italian study, “The Roles of Multiparametric MRI, PCA3, and PHI: Which Is The Best Predictor of Prostate Cancer After a Negative Biopsy?”[i] The authors recognize the keep reading
When you’re cruising along in good health, it’s easy to take that smooth road for granted. An annual physical with a PSA is a little like stopping at a red light and waiting till the light changes. When the physical ends, you figure it’s a green light and leave the office, expecting to go on keep reading
A study presented in 2014 at the AACR-Prostate Cancer Foundation Conference on Advances in Prostate Cancer Research reported a surprising relationship between vigorous exercise and the shape of blood vessels found in prostate cancer tumors. Men who walked faster prior to a diagnosis of prostate cancer were found to have more regularly shaped blood vessels keep reading
It’s tempting to become cynical about medicine when one hears reports of Medicare abuse or violations of Federal laws. These stories are especially rankling when greed appears to be the motive, and the victims are cancer patients. A few years ago, journalist Peter Waldman, writing for Bloomberg Business, assembled several anecdotes into a disturbing article keep reading